News

Prostate cancer is the most common type of cancer among men globally and the second leading cause of death for American men.

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

A new study co-led by a Saint Luke's researcher found that it may be possible to safely cut back on the level of monitoring of patients with stroke after thrombolysis administration.

During Stroke Awareness Month, Karin Olds, MD, stroke medical director at Saint Luke's Marion Bloch Neuroscience Institute, joined KMBC to discuss stroke risk factors and warning signs in younger adults.

This week, Marc Roth, MD, medical director of gastrointestinal oncology at Saint Luke’s Cancer Institute and interim chief of medical oncology, is breaking down these latest advancements and what they mean for patients.

Dr. Karin Olds, stroke director for Saint Luke's Marion Bloch Neuroscience Institute, joined KCTV to discuss the leading cause of long-term disability.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.

In her 30s, Jeannie Kautt, 66, was diagnosed with degenerative disc disease. Luckily, she had connections to the care she needed at Anderson County Hospital and Saint Luke's Marion Bloch Neuroscience Institute.

After seeking a second opinion at Saint Luke's, Mark Levin now walks tall—and pain free—knowing the right medical team, and a little faith, can work wonders.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.